Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from two decades of Rapamycin research
Master One Thing - Rapamycin Longevity Series
Introduction
Dr. Matt Kaeberlein discusses their pioneering research on mTOR, highlighting its impact on lifespan regulation, insights from genetic screens in yeast, and the potential implications of rapamycin inhibition on longevity.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
